Back
Folli Follie Commercial Manufacturing And Technical SA 10K Form
Buy
51
FLLIY
Folli Follie Commercial Manufacturing And Technical SA
Last Price:
6.10
Seasonality Move:
23.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FLLIY News And Ratings
See the #1 stock for the next 7 days that we like better than FLLIY
FLLIY Financial Statistics
Sales & Book Value
| Annual Sales: | $228.62M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $34.03 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 3.59960 |
|---|---|
| Net Income (TTM): | $238.88M |
| Gross Margin: | $80.22M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Folli Follie Commercial Manufacturing And Technical SA Earnings Forecast
Key Folli Follie Commercial Manufacturing And Technical SA Financial Ratios
- The Gross Profit Margin over the past 16 years for FLLIY is 35.09%.
- The Selling, General & Administrative Expenses for FLLIY have been equal to 69.02% of Gross Profit Margin.
- The Interest Expense is -11.93% of Operating Income.
- The Net Earning history of FLLIY is -56.95% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 9 years.
Folli Follie Commercial Manufacturing And Technical SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Current Symbol: | FLLIY |
| Website: | ffgroup.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
FLLIY Technical Analysis vs Fundamental Analysis
Buy
51
Folli Follie Commercial Manufacturing And Technical SA (FLLIY)
is a Buy
Is Folli Follie Commercial Manufacturing And Technical SA a Buy or a Sell?
-
Folli Follie Commercial Manufacturing And Technical SA stock is rated a Buy
The current Folli Follie Commercial Manufacturing And Technical SA [FLLIY] share price is $6.10. The Score for FLLIY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.